HIT Consultant August 23, 2024
Syed Hamza Sohail

What You Should Know:

Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.

– The new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring.

Qure.ai Enhances Lung Cancer Care with AI-Powered qCT LN Quant

Qure.ai has integrated qCT LN Quant into its AI-powered lung cancer care continuum in the US, providing comprehensive solutions to identify, measure, manage, and monitor lung health. These tools support clinicians in healthcare institutions, driving early detection and improving patient outcomes.

Key components of Qure.ai’s lung health solutions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Radiology, Technology
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever
Amazon Increases Total Investment in AI Startup Anthropic to $8 Billion

Share This Article